Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4102903
Max Phase: Preclinical
Molecular Formula: C12H9N3
Molecular Weight: 195.22
Molecule Type: Small molecule
Associated Items:
ID: ALA4102903
Max Phase: Preclinical
Molecular Formula: C12H9N3
Molecular Weight: 195.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: c1cncc(-c2c[nH]c3cnccc23)c1
Standard InChI: InChI=1S/C12H9N3/c1-2-9(6-13-4-1)11-7-15-12-8-14-5-3-10(11)12/h1-8,15H
Standard InChI Key: HLTAEMCUWJSTRY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 195.22 | Molecular Weight (Monoisotopic): 195.0796 | AlogP: 2.62 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.57 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.86 | CX Basic pKa: 5.32 | CX LogP: 1.28 | CX LogD: 1.28 |
Aromatic Rings: 3 | Heavy Atoms: 15 | QED Weighted: 0.65 | Np Likeness Score: -0.45 |
1. Shaw SJ, Goff DA, Lin N, Singh R, Li W, McLaughlin J, Baltgalvis KA, Payan DG, Kinsella TM.. (2017) Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus., 27 (11): [PMID:28408219] [10.1016/j.bmcl.2017.03.037] |
Source(1):